Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

12.9K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

NicheTrans: spatial-aware cross-omics translation.

Nature methods·2026
Same author

SOFisher: reinforcement learning-guided experiment designs for spatial omics.

Nature communications·2026
Same author

Tumor-Infiltrating mregDCs Restrain Anti-Tumor Immunity in Early Relapse HCC.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Benchmarking alignment methods for spatial transcriptomics data.

Nature computational science·2026
Same author

Scalable discovery of spatial multicellular patterns via neighborhood-to-sequence transformation.

Communications biology·2026
Same author

3d-OT: a deep geometry-aware framework for heterogeneous slices alignment of spatial multi-omics.

Nature methods·2026

Related Experiment Video

Updated: Sep 15, 2025

Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics
12:19

Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics

Published on: June 7, 2024

1.3K

Cancer therapy resistance from a spatial-omics perspective.

Yinghao Zhang1,2,3, Cheng Yang4, Xi Chen5

  • 1Department of Oncology, Shanghai Medical College, The Human Phenome Institute, Zhangjiang-Fudan International Innovation Center, Center for Integrative Spatial-Omics Research, Fudan University, Fudan University Shanghai Cancer Center, Shanghai, China.

Clinical and Translational Medicine
|July 18, 2025
PubMed
Summary

Cancer therapy resistance is a major hurdle. Spatial omics and computational methods are revolutionizing the understanding of tumor heterogeneity and the tumor microenvironment, offering new insights into cancer therapy resistance mechanisms.

Keywords:
cancer therapy resistancespatial omics

More Related Videos

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

10.7K
Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment
11:00

Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment

Published on: March 25, 2020

17.3K

Related Experiment Videos

Last Updated: Sep 15, 2025

Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics
12:19

Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics

Published on: June 7, 2024

1.3K
Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

10.7K
Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment
11:00

Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment

Published on: March 25, 2020

17.3K

Area of Science:

  • Oncology
  • Genomics
  • Bioinformatics

Background:

  • Cancer therapy resistance (CTR) poses a significant challenge in oncology.
  • Traditional methods lack the spatial resolution to fully characterize tumor and tumor microenvironment (TME) heterogeneity.

Purpose of the Study:

  • To review current methodologies for CTR research.
  • To highlight the impact of spatial omics and computational methods on understanding CTR.
  • To summarize recent studies and discuss future opportunities in spatial omics for CTR.

Main Methods:

  • Review of existing literature on cancer therapy resistance.
  • Analysis of spatial omics technologies and computational approaches.
  • Synthesis of recent studies across various cancer types and therapies.

Main Results:

  • Spatial omics technologies provide unprecedented insights into tumor and TME spatial organization.
  • These technologies are revolutionizing the understanding of CTR mechanisms.
  • Novel insights into CTR have been uncovered across diverse cancer types and therapies.

Conclusions:

  • Spatial omics, combined with computational methods, offers a powerful approach to study CTR.
  • This integrated approach is crucial for overcoming challenges in cancer treatment.
  • Future research directions in spatial omics hold significant promise for advancing oncology.